BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23374002)

  • 1. Prospective trial finds nystatin mouthwash effective prophylaxis for pulmonary invasive fungal infections that originate in the throat of patients with hematologic malignancies.
    Hu R; Jiang X; Wu Y
    Neoplasma; 2013; 60(3):315-21. PubMed ID: 23374002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for invasive pulmonary fungal infection in patients with hematological malignancies not receiving hematopoietic stem cell transplant.
    Hu R; Jiang XY; Wu Y
    Neoplasma; 2012; 59(6):669-75. PubMed ID: 22862167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical features of invasive pulmonary fungal infection secondary to malignant blood diseases].
    Sun XF; Han B; Feng J; Zhou DB; Wang SJ; Xu Y; Chen JL; Jiao L; Zhang W; Li J; Duan MH; Zhu TN; Zou N; Hua BL; Cai HC; Zhao YQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Oct; 31(5):575-9. PubMed ID: 19968074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of positive sputum culture for filamentous fungi].
    Shi XC; Liu ZY; Xu YC; Wang AX
    Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(4):245-8. PubMed ID: 20356538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical features and treatment of invasive fungal infection in 47 patients with hematological malignancies].
    Zhu Y; Chen SP; Shu YG; Xu YJ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 33(1):89-92. PubMed ID: 18245913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infections caused by filamentous fungi in patients with hematologic malignancies. A report of 391 cases by GIMEMA Infection Program.
    Pagano L; Girmenia C; Mele L; Ricci P; Tosti ME; Nosari A; Buelli M; Picardi M; Allione B; Corvatta L; D'Antonio D; Montillo M; Melillo L; Chierichini A; Cenacchi A; Tonso A; Cudillo L; Candoni A; Savignano C; Bonini A; Martino P; Del Favero A; ;
    Haematologica; 2001 Aug; 86(8):862-70. PubMed ID: 11522544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical analysis of invasive pulmonary fungal infections].
    Luo JM; Peng M; Xiao Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Apr; 32(2):141-6. PubMed ID: 20450541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature.
    Martino R; Lopez R; Sureda A; Brunet S; Domingo-Albós A
    Haematologica; 1997; 82(3):297-304. PubMed ID: 9234575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The value of assay of (1, 3)-β-D-glucan in bronchoalveolar lavage fluid for detection of invasive pulmonary fungal infection in critically ill patients in intensive care unit].
    Yang GH; Sheng ZY
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Feb; 24(2):90-5. PubMed ID: 22316540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral nystatin prophylaxis and neonatal fungal infections.
    Howell A; Isaacs D; Halliday R;
    Arch Dis Child Fetal Neonatal Ed; 2009 Nov; 94(6):F429-33. PubMed ID: 19321509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fungal prophylaxis in very low birth weight neonates: nystatin, fluconazole or nothing?
    Isaacs D
    Curr Opin Infect Dis; 2008 Jun; 21(3):246-50. PubMed ID: 18448968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial comparing ketoconazole and nystatin prophylactic therapy in neutropenic patients.
    Vogler WR; Malcom LG; Winton EF
    Cancer Invest; 1987; 5(4):267-73. PubMed ID: 3664330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of itraconazole as empirical antifungal therapy in febrile neutropenic patients with hematologic malignancies: an open-lable, multicenter, observational trial in a Chinese cohort.
    Cheng S; Zhou JF; Zou P; Huang XJ; Jin J; Shen ZX
    Chin Med J (Engl); 2011 Nov; 124(22):3670-5. PubMed ID: 22340222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Pulmonary Mucormycosis Based on a Polymerase Chain Reaction (PCR) Diagnosis in Patients with Hematologic Malignancies: A Report of Four Cases.
    Ino K; Nakase K; Nakamura A; Nakamori Y; Sugawara Y; Miyazaki K; Monma F; Fujieda A; Sugimoto Y; Ohishi K; Masuya M; Katayama N
    Intern Med; 2017; 56(6):707-711. PubMed ID: 28321075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fungal pneumonia due to molds in patients with hematological malignancies.
    Pagano L; Fianchi L; Leone G
    J Chemother; 2006 Aug; 18(4):339-52. PubMed ID: 17024788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of invasive fungal infections and rationale for antifungal therapy in patients with haematological malignancies.
    Hoenigl M; Zollner-Schwetz I; Sill H; Linkesch W; Lass-Flörl C; Schnedl WJ; Krause R
    Mycoses; 2011 Sep; 54(5):454-9. PubMed ID: 20406398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymerase-chain-reaction-based diagnosis of invasive fungal pulmonary infections in immunocompromised children.
    Kadmon G; Nahum E; Sprecher H; Stein J; Levy I; Schiller O; Schonfeld T
    Pediatr Pulmonol; 2012 Oct; 47(10):994-1000. PubMed ID: 22328487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral nystatin prophylaxis to prevent invasive candidiasis in Neonatal Intensive Care Unit.
    Ozturk MA; Gunes T; Koklu E; Cetin N; Koc N
    Mycoses; 2006 Nov; 49(6):484-92. PubMed ID: 17022766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination.
    Trenschel R; Peceny R; Runde V; Elmaagacli A; Dermoumi H; Heintschel von Heinegg E; Müller KD; Schaefer UW; Beelen DW
    Bone Marrow Transplant; 2000 Nov; 26(9):993-7. PubMed ID: 11100279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche dell' Adulto.
    Menichetti F; Del Favero A; Martino P; Bucaneve G; Micozzi A; Girmenia C; Barbabietola G; Pagańo L; Leoni P; Specchia G; Caiozzo A; Raimondi R; Mandelli F
    Clin Infect Dis; 1999 Feb; 28(2):250-5. PubMed ID: 10064240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.